These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 2656435)

  • 21. Antiarrhythmic plasma concentrations of NIK-244 on canine ventricular arrhythmias.
    Hashimoto K; Matsuzaki T; Haruno A
    J Cardiovasc Pharmacol; 1989 Dec; 14(6):892-8. PubMed ID: 2481779
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiarrhythmic effects of bisaramil on triggered arrhythmias produced by intracoronary injection of digitalis and adrenaline in the dog.
    Haruno A; Hashimoto K
    Jpn J Pharmacol; 1995 May; 68(1):95-102. PubMed ID: 7494388
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiarrhythmic effects of bisaramil in canine models of ventricular arrhythmia.
    Haruno A; Hashimoto K
    Eur J Pharmacol; 1993 Mar; 233(1):1-6. PubMed ID: 8472737
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effective plasma concentrations of antiarrhythmic drugs against sustained halothane-adrenaline arrhythmia in dogs.
    Shibuya T; Hashimoto K; Imai S
    J Cardiovasc Pharmacol; 1983; 5(4):538-45. PubMed ID: 6193348
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of a new antiarrhythmic drug TYB-3823 on canine ventricular arrhythmia models.
    Hashimoto K; Sugiyama A; Haruno A; Matsuzaki T; Hirasawa A
    J Cardiovasc Pharmacol; 1991 Feb; 17(2):336-42. PubMed ID: 1709241
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of gallopamil, a Ca2+ channel blocker in models of ventricular arrhythmia in dogs.
    Matsuzaki T; Haruno A; Hashimoto K
    Eur J Pharmacol; 1993 Feb; 231(3):363-70. PubMed ID: 8449229
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiarrhythmic plasma concentrations of pirmenol on canine ventricular arrhythmias.
    Hashimoto K; Watanabe K; Sugiyama A
    Jpn J Pharmacol; 1988 Oct; 48(2):273-82. PubMed ID: 3210450
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effects of a new antiarrhythmic drug, KW-3407, on canine ventricular arrhythmia models].
    Wu Z; Awaji T; Motomura S; Hashimoto K
    Nihon Yakurigaku Zasshi; 1992 Aug; 100(2):117-26. PubMed ID: 1427497
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of a new class I antiarrhythmic drug bidisomide on canine ventricular arrhythmia models.
    Zhenjiu W; Awaji T; Hirasawa A; Motomura S; Hashimoto K
    Mol Cell Biochem; 1993 Feb; 119(1-2):159-69. PubMed ID: 8455577
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute antiarrhythmic effects of intravenously administered amiodarone on canine ventricular arrhythmia.
    Awaji T; Wu ZJ; Hashimoto K
    J Cardiovasc Pharmacol; 1995 Dec; 26(6):869-78. PubMed ID: 8606522
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiarrhythmic effect of oxprenolol on halothane-epinephrine and coronary ligation induced ventricular arrhythmias in beagle dogs.
    Hashimoto K; Tsukada T; Matsuda H; Matsubara I; Imai S
    Jpn J Pharmacol; 1978 Aug; 28(4):535-44. PubMed ID: 32416
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiarrhythmic effects of an aconitine-like compound, TJN-505, on canine arrhythmia models.
    Arita J; Xue YX; Aye NN; Fukuyama K; Wakui Y; Niitsu K; Maruno M; Siying C; Hashimoto K
    Eur J Pharmacol; 1996 Dec; 318(2-3):333-40. PubMed ID: 9016923
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Negative chronotropic and inotropic effects of class I antiarrhythmic drugs assessed in isolated canine blood-perfused sinoatrial node and papillary muscle preparations.
    Sugiyama A; Takehana S; Kimura R; Hashimoto K
    Heart Vessels; 1999; 14(2):96-103. PubMed ID: 10651186
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiarrhythmic plasma concentrations of mexiletine on canine ventricular arrhythmias.
    Hashimoto K; Ishii M; Komori S
    J Cardiovasc Pharmacol; 1984; 6(2):213-9. PubMed ID: 6200706
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiarrhythmic effects of bupuranolol against canine ventricular arrhythmias induced by halothane-adrenaline or two-stage coronary ligation.
    Hashimoto K; Tsukada T; Matsuda H; Nakagawa Y; Imai S
    J Cardiovasc Pharmacol; 1979; 1(2):205-17. PubMed ID: 94390
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antiarrhythmic effects of optical isomers of disopyramide on canine ventricular arrhythmias.
    Nakamura M; Xue Y; Eto K; Hashimoto K
    J Cardiovasc Pharmacol; 1996 Mar; 27(3):368-75. PubMed ID: 8907798
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiarrhythmic properties of a prior oral loading of amiodarone in in vivo canine coronary ligation/reperfusion-induced arrhythmia model: comparison with other class III antiarrhythmic drugs.
    Nagasawa Y; Chen J; Hashimoto K
    J Pharmacol Sci; 2005 Mar; 97(3):393-9. PubMed ID: 15764841
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Broad sensitivity of rodent arrhythmia models to class I, II, III, and IV antiarrhythmic agents.
    Brooks RR; Miller KE; Carpenter JF; Jones SM
    Proc Soc Exp Biol Med; 1989 Jun; 191(2):201-9. PubMed ID: 2726785
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiarrhythmic and proarrhythmic effects of sematilide in canine ventricular arrhythmia models.
    Xue YX; Eto K; Akie Y; Hashimoto K
    Jpn J Pharmacol; 1996 Feb; 70(2):129-38. PubMed ID: 8866750
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effective plasma concentrations of aprindine in canine ventricular arrhythmias.
    Hashimoto K; Komori S; Ishii M; Kamiya J
    J Cardiovasc Pharmacol; 1984; 6(1):12-9. PubMed ID: 6199593
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.